Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/07/2010US20100254923 Composition and process for protecting cellular targets from aging and photodamage
10/07/2010US20100254916 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof
10/07/2010US20100254914 Nanoworms for in vivo tumor targeting
10/07/2010US20100254910 Methods and compositions for diagnostic and therapeutic targeting of cox-2
10/07/2010US20100254907 Methods for the treatment of tinnitus induced by cochlear excitotoxicity
10/07/2010US20100254904 Novel therapeutic delivery systems
10/07/2010US20100254901 Compositions comprising nucleic acid aptamers
10/07/2010US20100252050 Delivery system
10/07/2010DE102009016584A1 Schmelztablette, enthaltend ein Sildenafil-Salz Melting tablet containing a salt of sildenafil
10/07/2010DE102009016553A1 Sulfonamid- und Sulfoximin-substituierte Diaryldihydropyrimidinone und ihre Verwendung Sulfonamide and sulfoximine-substituted Diaryldihydropyrimidinone and their use
10/07/2010DE102009015702A1 Tabletten enthaltend Dapoxetin und Trockenverarbeitungsverfahren zu deren Herstellung Tablets containing dapoxetine and dry processing methods for their preparation
10/07/2010CA2794581A1 Method of treating osteoporosis
10/07/2010CA2794577A1 Semaphorin 3c (sema3c) inhibitor therapeutics, methods, and uses
10/07/2010CA2759187A1 Compositions for treatment of alzheimer's disease
10/07/2010CA2757726A1 Acrylamide compounds and the use thereof
10/07/2010CA2757722A1 Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
10/07/2010CA2757673A1 Dietary supplement comprising alpha-keto acids for supporting diabetes therapy
10/07/2010CA2757615A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010CA2757613A1 Methods and compositions for the specific inhibition of kras by asymmetric double-stranded rna
10/07/2010CA2757485A1 Pyrimidine substituted purine compounds as kinase (s) inhibitors
10/07/2010CA2757463A1 Lyophilization cakes of proteasome inhibitors
10/07/2010CA2757458A1 Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof
10/07/2010CA2757424A1 Novel derivatives of steroidal[3,2-c]pyrazole compounds with glucocorticoid activity
10/07/2010CA2757423A1 Novel amide derivatives of steroidal[3,2-c]pyrazole compounds with glucocorticoid activity
10/07/2010CA2757418A1 Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
10/07/2010CA2757415A1 Autotaxin inhibitors
10/07/2010CA2757413A1 Heterocyclic compounds as autotaxin inhibitors
10/07/2010CA2757411A1 Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
10/07/2010CA2757396A1 Medical composition for treatment or prophylaxis of eye diseases
10/07/2010CA2757373A1 L-ornithine phenyl acetate and methods of making thereof
10/07/2010CA2757337A1 Modified-release pharmaceutical drug composition
10/07/2010CA2757291A1 Medical composition for treatment or prophylaxis of glaucoma
10/07/2010CA2757231A1 1-heterocyclyl-1,5-dihydro-pyrazolo [3,4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
10/07/2010CA2757228A1 Co-crystal of etravirine and nicotinamide
10/07/2010CA2757222A1 Pharmaceutical composition for neuroprotective treatment in patients with ictus comprising citicoline and uric acid
10/07/2010CA2757208A1 Method for manufacturing 1,5-benzodiazepine derivative
10/07/2010CA2757190A1 Production method for ubiquinone powder for use in preparations and product thereof
10/07/2010CA2757189A1 Crystals of prasugrel hydrobromate
10/07/2010CA2757188A1 Pyrimidine compound
10/07/2010CA2757144A1 Low dose pipamperone in treating mood disorders
10/07/2010CA2757106A1 5-ht receptor modulating compounds
10/07/2010CA2757084A1 Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
10/07/2010CA2757082A1 A multipart fluid system and a system for regional citrate anticoagulation in an extracorporeal blood circuit
10/07/2010CA2757065A1 Antibacterial composition comprising 4 -isopropyl-3-methylphenol and zinc ions
10/07/2010CA2757056A1 A process for dimethylation of active methylene groups
10/07/2010CA2757032A1 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
10/07/2010CA2757019A1 Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
10/07/2010CA2756989A1 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
10/07/2010CA2756926A1 Pharmaceutical composition comprising a steroidal[3,2-c]pyrazole derivative and a second pharmaceutically active compound
10/07/2010CA2756877A1 Orally disintegrating coated tablet
10/07/2010CA2756873A1 Imidazo [2,1-b] [1,3,4] thiadiazole derivatives
10/07/2010CA2756871A1 Substituted heterocyclic compounds
10/07/2010CA2756870A1 Substituted indolo-pyridinone compounds
10/07/2010CA2756823A1 New compound of salvianolic acid l, preparation method and use thereof
10/07/2010CA2756815A1 Peri-fused pyrazolo-pyrimidine compounds
10/07/2010CA2756811A1 Liposome composition of eribulin or its pharmacologically permissible salt
10/07/2010CA2756810A1 Pyrazolo-pyrrolopyridine-dione derivatives useful in the treatment of cancer
10/07/2010CA2756809A1 Substituted tetrahydropyrazolo-pyrido-azepin compounds
10/07/2010CA2756808A1 Substituted indolo-piperidine compounds
10/07/2010CA2756807A1 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds
10/07/2010CA2756780A1 Renin inhibitors
10/07/2010CA2756397A1 Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof
10/07/2010CA2755928A1 Oxadiazole derivatives
10/07/2010CA2755878A1 Inhibition of biofilm organisms
10/07/2010CA2755132A1 Indolizine derivative and use thereof for medical purposes
10/07/2010CA2755077A1 Reduction of risk of obesity
10/07/2010CA2754646A1 Treatment of cancer with a humanized anti-egfr igg1 antibody and irinotecan
10/07/2010CA2754609A1 P38map kinase inhibitor
10/07/2010CA2753658A1 Anti-biofilm carbonate compounds for use in oral care compositions
10/07/2010CA2749218A1 Hydroxy-methyl isoxazole derivatives as gaba a modulators
10/07/2010CA2738573A1 Compositions of propane-1 sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide and uses thereof
10/07/2010CA2729621A1 Use of id4 for diagnosis and treatment of cancer
10/07/2010CA2699140A1 Nanoparticles for cancer sonodynamic and photodynamic therapy
10/06/2010EP2237042A1 Marker for determination of sensitivity to anti-cancer agent
10/06/2010EP2237035A2 Taxol derivatives for taxol immunoassay
10/06/2010EP2236629A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
10/06/2010EP2236620A2 Compositions and methods for detecting and treating HIV infection
10/06/2010EP2236609A2 DNA-based aptamers for human cathepsin G
10/06/2010EP2236511A2 Ligands of alpha-adrenoceptors and of dopamine, histamine, imidazoline and serotonin receptors and the use thereof
10/06/2010EP2236507A1 N-pyrazole-2-pyridinecarboxamide derivative
10/06/2010EP2236503A1 Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase
10/06/2010EP2236500A1 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof
10/06/2010EP2236498A1 Phenyl acetamide derivative
10/06/2010EP2236495A1 New salts for adding angiotensin conversion enzyme inhibitors to NO-donor acids, method of preparing same and pharmaceutical compositions containing them
10/06/2010EP2236494A1 Sulfonyl substituted 6-membered ring derivative
10/06/2010EP2236492A1 Novel dicarboxylic amino acid derivatives and the use thereof in the treatment of neurodegenerative diseases
10/06/2010EP2236491A2 Crystalline form of tigecycline and processes for preparation thereof
10/06/2010EP2236161A1 Polymer conjugates of opioid antagonists
10/06/2010EP2236160A2 Modified release dimebolin formulations
10/06/2010EP2236159A2 Modified release dimebolin compositions
10/06/2010EP2236158A1 New therapeutic approaches for treating neuroinflammatory conditions
10/06/2010EP2236147A1 Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of elderly
10/06/2010EP2236146A1 Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy
10/06/2010EP2236145A1 Pharmaceutical composition and combined agent
10/06/2010EP2236143A1 Antimicrobial agent for gram-positive bacteria
10/06/2010EP2236142A1 Medical use of conjugated polyelectrolytes
10/06/2010EP2236141A1 siDNA oligonucleotide as antiviral agent against Herpes virus Infections
10/06/2010EP2236140A1 Regulation of phospholipase D activity
10/06/2010EP2236139A1 Combination therapy of erlotinib with an anti-IGF-1R antibody, which does not inhibit binding of insulin to the insulin receptor
10/06/2010EP2236138A1 Low dose pipamperone in treating mood and anxiety disorders
1 ... 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 ... 7860